Sorush Niknamian
BACKGROUND
[1] MRSB Member of Royal Society of Biology (RSB) – (Membership Number: P0126512)
[2] Weston A. Price Honorary and Gifted Membership by Mrs. Sally Fallon Morell the President of WAPF.
[3] Member of American Association for Cancer Research (AACR) – Membership ID: 373521
[4] Member of International Society of Infectious Diseases (ISID)
[5] Member of American Institute of Chemical and Biological Engineers. (AIche) – (Membership Number: 9901787645)
[6] Member of International Society for Environmental Information Sciences
(ISEIS)
[7] Member of Royal Biochemical Society, London, Charles Darwin House, (Membership Number: 01077285)
[8] Member of American Association for Advancements of Science (AAAS) – (Membership ID: 41563701)
OTHER INTERESTS
SHORT BIOGRAPHY
Professor Dr. Sorush Niknamian (Professor Sir Sorush Niknamian). Ph.D in Cellular and Molecular Biology from the University of Cambridge. He is a CSci (Chartered Scientist), RSciTech (Registered Science Technician), RSci (Registered Scientist) and Science Council, United Kingdom and Indiana Cancer Consortium (ICC) certified. He is the Board member of Weston A. Price Foundation in Washington, United States, Member of American Association for Cancer Research (AACR), Ambassador of European Association for Cancer Research (EACR), Member of Federal Health Professionals in the United States Marine Forces, Army Forces and Military Medicine, Registered Researcher in the U.S. Government's System for Award Management (NAS) and certified member of Royal Society of Biology (MRSB) and the Royal Society of the Great Britain. He has been published 27 books in medical and biological sciences including cancer prevention and treatment. He has published more than 25 research articles in international high impact journals in many fields of medicine. He has been working on cancer treatment, Cause and Prevention alongside Professor Thomas N. Seyfried, Professor Stephanie Seneff, Professor Domonic D’Agostino and Miriam Kalamian. He has hypothesized cancer as an evolutionary metabolic disease (Disorder) and introduced a new protocol in the treatment of cancer. He is a Professional Reviewer at National Institute for Health Research (NIHR), United Kingdom, Editor of the Publishing Research Group, American Society of Clinical Oncology (ASCO), Member of peer review corps at Journal of Clinical Oncology (JCO), JCO Clinical Cancer Informatics, JCO Precision Oncology, Journal of Oncology Practice, Dove Medical Press (Adolescent Health, Medicine and Therapeutics Journal), Dove Medical Press. (Biologics: Targets and Therapy Journal) and Dove Medical Press (Cancer Management and Research) and etc. He is the Guest editor of Nature Medicine Journal and the editorial Board Member of Global Access Publishers (Global Journal of Neurology). He is a nominee of Edison Award 2019.
RESEARCH
Oncology; Multiple Sclerosis; Cancer Metabolism; Cancer Treatment, Biochemistry; Cancer Biology; Evolution; Coronary Heart Disease and Nutrition.
EDUCATION & TRAINING
Professor of Cell and Molecular Biology, University of Cambridge, UK



